Please login to the form below

Janus kinase inhibitors are amongst the most read abstracts at the American College of Rheumatology 2015

Rheumatologists eagerly await trial data for Janus kinase inhibitors

Data presented during ACR 2015 highlighted the potential impact the Janus kinase inhibitors (JAKi) will bring to optimising treatment for rheumatoid arthritis patients. Read more here http://goo.gl/djQAML

19th November 2015

Share

Company Details

Lucid Group Communications Limited

+44 01494 755712

Contact Website

Address:
Burleighfield House
London Road
Loudwater
Bucks
HP10 9RF
UK

Latest content on this profile

The Lucid Group Futures Academy
A graduate programme designed to recruit the exceptional, so that we deliver the outstanding.
Lucid Group Communications Limited
It’s Freshers' week at Lucid Group
Lucid launch their Futures Academy
Lucid Group Communications Limited
A New Managing Director Appointed for Lighthouse Medical Communications US
Lucid Group boost their US operations with the appointment of Andy Willmer as Managing Director for Lighthouse Medical Communications
Lucid Group Communications Limited
The magic of mobile working
Lucid Communications Group Ltd. has implemented new ways of agile working across its offices to attract top talent and facilitate the company’s continued growth in the strategic medical communications industry.
Lucid Group Communications Limited
Lucid CEO discusses communication excellence in a multimedia world

Lucid Group Communications Limited
Lucid tackles Tough Mudder 2017

Lucid Group Communications Limited